Literature DB >> 30114413

Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome.

Rebecca J Kapphahn1, Michael J Richards2, Deborah A Ferrington1, Steven J Fliesler3.   

Abstract

Oxidative modification of proteins can perturb their structure and function, often compromising cellular viability. Such modifications include lipid-derived adducts (e.g., 4-hydroxynonenal (HNE) and carboxyethylpyrrole (CEP)) as well as nitrotyrosine (NTyr). We compared the retinal proteome and levels of such modifications in the AY9944-treated rat model of Smith-Lemli-Opitz syndrome (SLOS), in comparison to age-matched controls. Retinas harvested at 3 months of age were either subjected to proteomic analysis or to immuno-slot blot analysis, the latter probing blots with antibodies raised against HNE, CEP, and NTyr, followed by quantitative densitometry. HNE modification of retinal proteins was markedly (>9-fold) higher in AY9944-treated rats compared to controls, whereas CEP modification was only modestly (≤2-fold) greater, and NTyr modification was minimal and exhibited no difference as a function of AY9944 treatment. Anti-HNE immunoreactivity was greatest in the plexiform and ganglion cell layers, but also present in the RPE, choroid, and photoreceptor outer segment layer in AY9944-treated rats; control retinas showed minimal HNE labeling. 1D-PAGE/Western blot analysis of rod outer segment (ROS) membranes revealed HNE modification of both opsin and β-transducin. Proteomic analysis revealed the differential expression of several retinal proteins as a consequence of AY9944 treatment. Upregulated proteins included those involved in chaperone/protein folding, oxidative and cellular stress responses, transcriptional regulation, and energy production. βA3/A1 Crystallin, which has a role in regulation of lysosomal acidification, was down-regulated. Hence, oxidative modification of retinal proteins occurs in the SLOS rat model, in addition to the previously described oxidation of lipids. The results are discussed in the context of the histological and physiological changes that occur in the retina in the SLOS rat model.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholesterol; Oxidation; Oxidative stress; Protein modification; Retina; Smith-Lemli-Opitz

Mesh:

Substances:

Year:  2018        PMID: 30114413      PMCID: PMC6361703          DOI: 10.1016/j.exer.2018.08.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  60 in total

1.  Proteasome function and protein oxidation in the aged retina.

Authors:  Jennifer L Louie; Rebecca J Kapphahn; Deborah A Ferrington
Journal:  Exp Eye Res       Date:  2002-09       Impact factor: 3.467

Review 2.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

3.  Expression of βA3/A1-crystallin in the developing and adult rat eye.

Authors:  Geetha Parthasarathy; Bo Ma; Cheng Zhang; Celine Gongora; J Samuel Zigler; Melinda K Duncan; Debasish Sinha
Journal:  J Mol Histol       Date:  2011-01-04       Impact factor: 2.611

Review 4.  Two-dimensional gel electrophoresis of proteins.

Authors:  M J Dunn
Journal:  J Chromatogr       Date:  1987-07-17

5.  SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter.

Authors:  C Sagné; M F Isambert; J P Henry; B Gasnier
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

Review 6.  Biological and pathophysiological roles of end-products of DHA oxidation.

Authors:  Valentin P Yakubenko; Tatiana V Byzova
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-10-03       Impact factor: 4.698

Review 7.  Autophagy in neurons: a review.

Authors:  K E Larsen; D Sulzer
Journal:  Histol Histopathol       Date:  2002       Impact factor: 2.303

8.  Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes.

Authors:  Libin Xu; Todd A Davis; Ned A Porter
Journal:  J Am Chem Soc       Date:  2009-09-16       Impact factor: 15.419

9.  Modified alpha A crystallin in the retina: altered expression and truncation with aging.

Authors:  Rebecca J Kapphahn; Cheryl M Ethen; Elizabeth A Peters; LeeAnn Higgins; Deborah A Ferrington
Journal:  Biochemistry       Date:  2003-12-30       Impact factor: 3.162

10.  Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration.

Authors:  Matthew Krilis; Miao Qi; Michele C Madigan; Jason W H Wong; Mahmoud Abdelatti; Robyn H Guymer; John Whitelock; Peter McCluskey; Peng Zhang; Jian Qi; Alex P Hunyor; Steven A Krilis; Bill Giannakopoulos
Journal:  Oncotarget       Date:  2017-07-25
View more
  4 in total

1.  Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome.

Authors:  Bruce A Pfeffer; Libin Xu; Steven J Fliesler
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 6.208

Review 2.  Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.

Authors:  Steven J Fliesler; Libin Xu
Journal:  Molecules       Date:  2018-10-22       Impact factor: 4.411

3.  Reactive Sterol Electrophiles: Mechanisms of Formation and Reactions with Proteins and Amino Acid Nucleophiles.

Authors:  Ned A Porter; Libin Xu; Derek A Pratt
Journal:  Chemistry (Basel)       Date:  2020-05-06

4.  Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems.

Authors:  J Víctor Álvarez; Susana B Bravo; María García-Vence; María J De Castro; Asteria Luzardo; Cristóbal Colón; Shunji Tomatsu; Francisco J Otero-Espinar; María L Couce
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.